Releaser – Quality Assurance

Baxter introduces the IV Verify Line Labeling System, an automated solution to improve IV labeling in healthcare settings. * New system offers a standardized and simplified alternative to traditional handwritten line labeling that supports safer medication administration * Solution aims to streamline nursing workflow, helping to save clinician time and reduce likelihood of medication errors related to IV line labeling inconsistencies DEERFIELD, Ill. - 2026-03-30 Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and platforms, today debuted the IV Verify Line Labeling System, an automated solution, at the 2026 American Organization for Nursing Leadership Conference. The IV Verify system is designed to streamline nursing workflows, save clinician time and support safer medication administration at the bedside. Baxter's launch of the product is the result of a strategic and exclusive distribution agreement with Vigilant Software, a leader in medication management safe practices. Medication errors remain a persistent challenge in healthcare settings, particularly in high-acuity areas where multiple infusions may be running simultaneously. Unclear or inconsistent IV line labeling practices can contribute to line tracing errors or incorrect medication administration.[i,ii] In a 10-hospital study of intensive care units (ICUs), 60 percent of IV infusion labels were not compliant with hospital policies[.i] With the IV Verify system, clinicians scan a medication's barcode and the system instantly prints a three-part adhesive label featuring the drug name, administration time and tubing change times, which can then be applied to the tubing - offering a clear, simplified solution that can help support patient safety and labeling compliance. "Frontline clinicians manage complexity every day, and even small inefficiencies can create risk," said Athar Mirza, U.S. and Canada general manager of Baxter's Infusion Therapies and Platforms division. "At Baxter, we are committed to supporting nurses at the bedside with tools that can help make care safer and more efficient. The IV Verify system replaces handwritten labels with easy-to-use technology that supports consistency, saves time and helps clinicians confidently trace IV lines so they can spend more time focused on their patients." The IV Verify system includes a printer, labels and patented ink-free technology and is designed to support: * Patient Safety: Replaces inconsistent handwritten line labels with clear, standardized identification to help reduce the risk of medication error and support safe infusion practices at the bedside. One healthcare system saw increased compliance in line labeling at the point of care when using the IV Verify system, and a meaningful reduction in central line associated blood stream infections (CLABSI) when implemented as part of a health system's CLABSI bundle.[iii] * Nurse Efficiency: Streamlines IV line identification and tracing, helping clinicians save time and reduce cognitive burden. Color-coded labels indicate tubing change day and time, which aims to eliminate the need for manual calculations of line expiration. Additionally, studies show that clinicians saved an average of one to two minutes per IV setup with the IV Verify system, time that can be redirected to patient interactions.[iv] * Clarity: System prints color-coded and liquid-resistant labels designed to remain legible in busy clinical environments where multiple infusions may be running at the same time. Two additional labels - closer to the infusion pump and patient ends of tubing - aim to provide greater clarity compared to the traditional single, handwritten label. The introduction of the IV Verify Line Labeling System reflects Baxter's ongoing commitment to helping advance safer infusion practices through practical, clinician-focused innovation. The product is available now in the U.S. Learn more here. Vigilant Software is a healthcare technology company founded by a practicing clinician and focused on supporting medication safety and clinical workflow through automation. About Baxter At Baxter, Baxter is everywhere healthcare happens - and everywhere it is going, with essential solutions in the hospital, physician's office and other sites of care. For nearly a century, its customers have counted on Baxter as a vital and trusted partner. And every day, millions of patients and healthcare providers rely on its unmatched portfolio of connected solutions, medical devices, and advanced injectable technologies. Approximately 37,500 Baxter team members live its enduring Mission: to Save and Sustain Lives. Together, Baxter is redefining how care is delivered to make a greater impact today, tomorrow, and beyond. To learn more, visit www.baxter.com and follow Baxter on X, LinkedIn and Facebook. Rx Only. For safe and proper use of this device, refer to the full Instructions for Use. This release includes forward-looking statements concerning potential benefits associated with IV Verify. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: demand and market acceptance for, and competitive pressures (including pricing) related to, new and existing products; product development risks; inability to create additional production capacity in a timely manner or the occurrence of other manufacturing or supply difficulties; satisfaction of regulatory and other requirements; actions of regulatory bodies and other governmental authorities; product quality, manufacturing or supply, or patient safety issues; changes in law and regulations; and other risks identified in Baxter's most recent filing on Form 10-K and Form 10-Q and other SEC filings, all of which are available on Baxter's website. Baxter does not undertake to update its forward-looking statements. Baxter is a registered trademark of Baxter International Inc. IV VERIFY is a trademark of Vigilant Labs, Inc. and is used under license. i Schnock K, Dykes P, Albert J, et al. The frequency of intravenous medication administration errors related to smart infusion pumps: a multihospital observational study. BMJ Qual Saf. 2017. 26(2):131-140. ii Lassiter Z, Brockman B, Brown M, et al. Enhancing CLABSI prevention through smart IV tubing labeling technology: a quality improvement project to improve bundle compliance and reduce nursing burden. Poster presented at: AVA Annual Scientific Meeting; 2025; Kissimmee, Florida. iii Hinton A and Olson J. Utilizing Technology: Increasing IV Tubing Labeling Compliance to Prevent Central Line Associated Blood Stream Infection (CLABSI). Indiana University Health. 2022. iv Tinio GR, Meister U. On-demand IV infusion label printer. Northwestern Medicine-Delnor Hospital; 2017. Internal report.

Baxter launches new technology to advance IV safety and efficiency. March 30, 2026- Baxter International Inc. debuted the IV Verify Line Labeling System, an automated solution, at the 2026 American Organization for Nursing Leadership Conference. The IV Verify system is designed to streamline nursing workflows, save clinician time and support safer medication administration at the bedside. Baxter's launch of the product is the result of a strategic and exclusive distribution agreement with Vigilant Software, a leader in medication management safe practices. Medication errors remain a persistent challenge in healthcare settings, particularly in high-acuity areas where multiple infusions may be running simultaneously. Unclear or inconsistent IV line labeling practices can contribute to line tracing errors or incorrect medication administration. In a 10-hospital study of intensive care units (ICUs), 60 percent of IV infusion labels were not compliant with hospital policies[.] With the IV Verify system, clinicians scan a medication's barcode and the system instantly prints a three-part adhesive label featuring the drug name, administration time and tubing change times, which can then be applied to the tubing - offering a clear, simplified solution that can help support patient safety and labeling compliance. The IV Verify system includes a printer, labels and patented ink-free technology and is designed to support: * Patient Safety * Nurse Efficiency * Clarity The introduction of the IV Verify Line Labeling System reflects Baxter's ongoing commitment to helping advance safer infusion practices through practical, clinician-focused innovation. The product is available now in the U.S. Learn more here.

Pet Partners and the Baxter Foundation expand Therapy Animal programs to support 100,000 patients and healthcare workers in two-year pilot. * Largest Single Investment from a Corporate Foundation Aims to Strengthen Healthcare Resilience by Advancing Therapy Animal Visits in U.S. Healthcare Settings BELLEVUE, Wash., and DEERFIELD, Ill. - 2026-03-25 Pet Partners, the nation's leading organization dedicated to improving human health and well-being through therapy animal interactions, and the Baxter Foundation, the philanthropic arm of Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced a new partnership to expand access to therapy animal programs in healthcare settings across the country. The initiative will begin as a two-year pilot program in key regions, including Northern California, Upstate New York and Greater Chicago, IL, with the goal of reaching 100,000 patients and healthcare professionals and creating a more resilient healthcare system. As healthcare workers grapple with high levels of stress and burnout, while patients and their families cope with the emotional challenges of treatment, therapy animals can help provide much-needed moments of calm, connection and comfort. Research shows that interactions with therapy animals can lead to lower pain ratings for patients, as well as reduced symptoms of anxiety and depression.[i] And for healthcare workers, even brief, five-minute therapy dog visits have been shown to lower stress, anxiety and cortisol levels.[ii] Yet, many healthcare facilities lack the administrative support and volunteer base needed to develop and sustain animal therapy programs. Together, Pet Partners and the Baxter Foundation aim to provide resources, training and infrastructure to help more healthcare settings integrate therapy animal visits into their care practices. "Our collaboration with Pet Partners was inspired by the story of a young patient named Izzy who welcomed a dog into her life during her cancer treatment and named him Baxter - after the Baxter infusion pump that supported her chemotherapy," said Stacey Eisen, Baxter's chief communications officer and president of the Baxter Foundation. "Hearing how much comfort Baxter [the dog] brought Izzy and her family was a powerful reminder of how healing the human-animal bond can be during incredibly challenging moments. At Baxter, we support patients and care teams every day through our products and services, and this partnership allows us to extend that support at the bedside and across the hospital in a new and deeply meaningful way." The Baxter Foundation's investment will support Pet Partners with the following objectives: * Expand access to therapy animals: Bring therapy animals to more patients and healthcare workers by increasing visits to healthcare settings and recruiting more Pet Partners volunteers. * Advance animal-assisted interventions: Support volunteer education and training to ensure safe, evidence-based therapy animal visits, including updating Pet Partners' safety and infection control course. * Strengthen industry research: Conduct a study on the impact of therapy animals on healthcare professionals to expand public and professional understanding of animals' roles in supporting a more resilient healthcare system. * Engage Baxter employees: Provide hands-on opportunities for Baxter employees to get involved through volunteering, workplace well-being events and more. "We are thrilled to partner with the Baxter Foundation to expand access to therapy animals and deepen the impact of animal-assisted interventions in healthcare," said Annie Peters, CEO of Pet Partners. "Together, we are creating meaningful moments that support resilience for healthcare workers and comfort for patients. This partnership represents an exciting step forward in advancing the human-animal bond in healthcare settings nationwide." About Pet Partners Pet Partners is the leader in the therapy animal field for registering volunteer teams. Since 1977, Baxter has supported thousands of teams in making millions of meaningful visits across the country and around the world. Through the human-animal bond, Baxter can improve the physical, social, and emotional lives of both the people and animals involved. Pet Partners supports volunteer teams by offering the highest quality preparation, an unmatched approach to evaluation and registration - for nine different types of animals - and a focus on connections. Baxter elevate the importance of therapy animal visits, and its teams help build a healthier and happier world for Baxter all. Whether or not you have a pet, learn more about sharing the human-animal bond by visiting petpartners.org. About the Baxter Foundation Every day, Baxter and the Baxter Foundation strive to make a meaningful difference in the lives of people who depend on its products, and in the communities where its employees live and work. The Foundation helps advance Baxter's Mission to Save and Sustain Lives by partnering with organizations around the world to increase access to healthcare for the underserved, develop the next generation of innovators who will lead the way in advancing healthcare and create a positive, long-lasting impact in communities globally. For more information, please visit Baxter's Corporate Responsibility page. Baxter is a registered trademark of Baxter International Inc. or its subsidiaries.